Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/13474
Full metadata record
DC FieldValueLanguage
dc.contributor.authorHowells, David Williamen
dc.contributor.authorLiberatore, G Ten
dc.contributor.authorWong, J Yen
dc.contributor.authorDonnan, Geoffrey Aen
dc.date.accessioned2015-05-16T03:19:50Z
dc.date.available2015-05-16T03:19:50Z
dc.date.issued1996-07-01en
dc.identifier.citationJournal of the Neurological Sciences; 139(1): 125-30en
dc.identifier.govdoc8836983en
dc.identifier.otherPUBMEDen
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/13474en
dc.description.abstractThe improvements obtained by grafting dopamine-rich tissues into the striatum of patients with Parkinson's disease are generally attributed to production and release of dopamine by the graft. However, it is becoming increasingly clear that grafting also stimulates the host dopaminergic system. We provide evidence in a mouse model of striatal damage that surgical cavitation induces a concerted response from the dopaminergic system with proliferation of striatal presynaptic dopamine uptake sites, increased tyrosine hydroxylase activity, increased concentrations of dopamine, dihydroxyphenylacetic acid and homovanillic acid. The response increases with time and ultimately includes contralateral stimulation of striatal tyrosine hydroxylase activity and elevation of dihydroxyphenylacetic acid and homovanillic acid concentrations. The time course and extent of the host dopaminergic response suggests that it may make a significant contribution to observed clinical improvements after intrastriatal transplantation in human parkinsonism.en
dc.language.isoenen
dc.subject.other3,4-Dihydroxyphenylacetic Acid.metabolismen
dc.subject.otherAnimalsen
dc.subject.otherBrain.metabolismen
dc.subject.otherBrain Tissue Transplantationen
dc.subject.otherCorpus Striatum.metabolism.pathologyen
dc.subject.otherDihydroxyphenylalanine.metabolismen
dc.subject.otherDopamine.metabolismen
dc.subject.otherFunctional Lateralityen
dc.subject.otherHomovanillic Acid.metabolismen
dc.subject.otherHumansen
dc.subject.otherMaleen
dc.subject.otherMazindol.metabolismen
dc.subject.otherMiceen
dc.subject.otherMice, Inbred C57BLen
dc.subject.otherParkinson Disease.pathology.surgeryen
dc.subject.otherReference Valuesen
dc.subject.otherSynapses.metabolismen
dc.subject.otherTime Factorsen
dc.subject.otherTyrosine 3-Monooxygenase.metabolismen
dc.titleDopaminergic responses to striatal damage.en
dc.typeJournal Articleen
dc.identifier.journaltitleJournal of the neurological sciencesen
dc.identifier.affiliationDepartment of Neurology, University of Melbourne, Austin, Australiaen
dc.description.pages125-30en
dc.relation.urlhttps://pubmed.ncbi.nlm.nih.gov/8836983en
dc.type.austinJournal Articleen
local.name.researcherDonnan, Geoffrey A
item.grantfulltextnone-
item.openairetypeJournal Article-
item.languageiso639-1en-
item.fulltextNo Fulltext-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
crisitem.author.deptThe Florey Institute of Neuroscience and Mental Health-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

22
checked on Nov 21, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.